“Efficacy and Safety of up to Two Years of Tralokinumab Treatment in Adults of Different Racial Subgroups With Moderate-to-Severe Atopic Dermatitis”. SKIN The Journal of Cutaneous Medicine 7, no. 2 (March 13, 2023): s144. Accessed May 17, 2025. https://skin.dermsquared.com/skin/article/view/2025.